Provectus Therapeutics

We are tired of Trial-and-error and one-size-fits-all approaches. In the age of AI & Personalised Treatmnet, we help you identify your tumor’s characteristics and drug resistance profile under > 100 approved cancer drug to explore all possibility. KNOW YOUR CANCER CELL BEFORE YOUR TREATMENT. Explore what we can do : https://lnkd.in/gpPZVfjx #cancertreatment #personalization #future #AI #drugresistance

At Provectus Therapeutics, we are redefining the landscape of cancer treatment through Predictive Precision & Innovation. Our mission is to leverage advanced technologies, including AI and precision medicine, to empower patients with personalized cancer treatment by identifying tumor resistance before it begins. Join us at our upcoming Investor Meeting to discover how we together can shape a better future through our cutting-edge technology and vision. 📅 Date: 15/11/2024 (Hong Kong Time Zone - GMT+8) 🕒 Time: 1500 - 1600 📍 Location: Online Join us to see how we are shaping the future of oncology. This is your chance to invest in a company that not only promises but delivers innovation with a profound impact on healthcare. Registration Link : https://lnkd.in/gUi3k4AX Together, let's pioneer a future where cancer is no longer a life sentence, but a challenge we conquer with precision, innovation, and care. #CancerCare #Innovation #PrecisionMedicine #Healthcare #AI #InvestorMeeting

🌟 Exploring Every Route to Survival 🌟 At the heart of our mission is a deep commitment to exploring every possible treamtent route for cancer patients by leveraging our AI and cutting-edge technologies. We equip doctors with the understanding of patients' drug responses and tumor composition at the early diagnostic stage, enabling them to tailor the best treatment for each patient. Join us in our quest to rekindle the flame of hope for all humanity, as Prometheus once brought fire to mankind 🌏 . #CancerCare #Survival #PersonalizedMedicine #AI #Hope #HealthcareVision #Inspiration #PatientCare

🚀 Redefine Cell Culture with Provectus Therapeutics! 🚀 We're excited to introduce our cutting-edge technology in providing unprecedented resolution for cancer research in tumor heterogeneity, phenotypic variability and off-target mechanism. Here’s why you should partner with us: 🔬 Up to 1 Million Single Cell Culture: Achieve unprecedented resolution single cell analysis. 🤖 AI-powered Single Cell Analysis: Leverage the power of AI for detailed and accurate single cell analysis. 💊  Drug Responses : Extract over 180 morphological and phenotypic features from each cancer cell for multidimensional analysis (i.e. multiomics, morphology and cell viability). Ready to take your cancer research to the next level? Connect with us today to explore collaboration opportunities! 🌐 [https://lnkd.in/gpPZVfjx] ✉️ [business@provectustherapeutics.com] #CancerResearch #CellCulture #DrugDevelopment #AIinHealthcare #Biotechnology #ResearchCollaboration

We are thrilled to announce that Provectus Therapeutics has been selected as one of the top 20 startups to advance to the Final Pitching Day at this year’s prestigious event! This recognition comes after a rigorous selection process by a panel of expert judges. Join us on June 27th to see how we utilize cutting-edge technologies to explore tumor heterogeneity and make personalized cancer treatment a reality for every patients. #startupexpress2024 #biotech #cancer #AI #personalization

We are thrilled to announce our entry into Hong Kong Science Park, a major milestone that marks the beginning of an exciting new chapter for our research endeavors. This strategic move will provide us with world-class facilities and a collaborative environment to push the boundaries of innovation and elevate our research to unprecedented heights. Stay tuned as we embark on this journey to drive groundbreaking advancements in our field! Find more at https://lnkd.in/gpPZVfjx #HKSTP #Biotech #Oncology #AI #Personalizedtreatment

Advanced single-cell culture device, paired with our proprietary AI system, achieves unprecedented resolution for research on tumor heterogeneity, off-target mechanisms, and phenotypic variability. Antibody-Drug Conjugates (ADCs) in breast cancer will be our primary focus area in drug development and cancer treatment. If you are interested in our technology or any form of R&D collaboration, please feel free to reach out. #ADC #cancer #treatment #drugdevelopment

‘The National Cancer Institute at the National Institutes of Health provides a wealth of information on functional drug testing in cancer treatment. The institute underscores the importance of identifying specific genetic mutations in tumors to guide treatment decisions and improve patient outcomes. As technology continues to advance and more studies find success with the 'try-everything tactic, it's clear that the future of cancer treatment lies in personalized medicine and targeted therapies.’ High throughput functional drug testing shows the promise of personalised cancer treatment for every patients. But there are challenges for adoption : 1. Limited sample from patients 2. High cost in drug testing To achieve personalised cancer treatment, Provectus Therapeutics embraces state-of-the-art technologies, Artificial Intelligence & Single Cell Technology, to overcome barriers of conventional functional drug testing. Find out more : https://lnkd.in/gpPZVfjx https://lnkd.in/gZniGqhy

🚀 **Big News from Provectus Therapeutics!** 🚀 We are thrilled to announce that Provectus Therapeutics has been selected as an incubatee under HKSTP Incu-Bio Program! This marks a significant milestone in our journey as we continue to innovate and push the boundaries in the world of medical therapeutics. Being part of the HKSTP Incu-Bio Program is not just an honor; it's a testament to the hard work, dedication, and visionary science that our team embodies. As we move forward, the concept of personalized cancer treatment edges closer to fruition. We are Provectus Therapeutics, biotech venture aiming to customerise cancer treatment for every individuals. Find out more : https://lnkd.in/gpPZVfjx #personalisedtreatment #cancer #AI #biotech

High-throughput drug screening customizes therapy at an individual level by empirically determining the most effective (cancer /non-cancer) drugs (or drug combinations) for each patient's unique cancer cells. This patient-centric strategy seeks to enhance treatment efficacy by achieving personalised treatment and moving beyond one-size-fits-all solutions. Provectus Therapeutics shares the same vision by implementing properitory technology to identify tumor heterogeneity and offer a fast, efficient and accurate pre-treatment prediction for patients. Transform the industry with the strategy - from Precision to Personalization, for the dream of personalised treatment. Find out more on https://lnkd.in/gpPZVfjx. #precisionmedicine #personalisedmedicine #cancer https://lnkd.in/g4ZQNfAi